Cardiac complications after stem cell transplantation.
Cardiac insufficiency / toxicity has been recognized as a complication of intensive cytotoxic therapy used in stem cell transplant setting. The incidence of clinically significant cardiac toxicity following high dose chemotherapy ranges between 2 - 43% with mortality of 2 - 9%. Two patients are reported who developed life-threatening cardiac complications following cyclophosphamide and busulphan therapy requiring pericardiocentesis and pericardiectomy.
Satti
Tariq Mahmood
TM
Department of Haematology, AFBMTC, Rawalpindi.
Ullah
Khalil
K
Ahmed
Pervez
P
Raza
Shahid
S
Chaudhry
Qamar-Un- Nisa
QU
Ikram
Aamer
A
Kamal
Muhammad Khalid
MK
Akhtar
Furrukh Mahmood
FM